Beijing Succeeder Technology (SHSE:688338) 5-Year EBITDA Growth Rate : 7.40% (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Beijing Succeeder Technology 5-Year EBITDA Growth Rate?

Beijing Succeeder Technology's EBITDA per Share for the three months ended in Mar. 2025 was ¥0.21.

During the past 12 months, Beijing Succeeder Technology's average EBITDA Per Share Growth Rate was -16.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 5.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 7.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 9 years, the highest 3-Year average EBITDA Per Share Growth Rate of Beijing Succeeder Technology was 27.70% per year. The lowest was 4.80% per year. And the median was 10.90% per year.

Competitive Comparison of Beijing Succeeder Technology's 5-Year EBITDA Growth Rate

For the Medical Devices subindustry, Beijing Succeeder Technology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Succeeder Technology's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Succeeder Technology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Beijing Succeeder Technology's 5-Year EBITDA Growth Rate falls into.

Save Embed

;

Save Embed

;

Beijing Succeeder Technology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Beijing Succeeder Technology (SHSE:688338) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Beijing Succeeder Technology 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Beijing Succeeder Technology's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Succeeder Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Succeeder Technology Inc (SHSE:688338) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Innovation Road, No. 1, Xingchang Road, Block 1A, No. 27, Science and Technology Park, 3rd Floor, Building 1, Changping District, East District, East District, Beijing, CHN, 102200

Website

http://www.succeeder.com.cn

Beijing Succeeder Technology Inc is engaged in production and sales of detection instruments, reagents and consumables in the field of in vitro diagnosis of thrombosis and hemostasis. The company develops, manufactures and sells in-vitro diagnostic products including coagulation analyzers and reagents, blood rheology analyzers, ESR analyzers and platelet aggregation analyzers. Its product portfolio includes Fully Auto Coagulation Analyzer; Semi Auto Coagulation Analyzer; ESR Analyzer; Platelet Aggregation Analyzer; and Coagulation Reagents.

Executives

Le Jia Min	Core technical personnel
Yu Song Yan	Core technical personnel
Li Gang	Core technical personnel
Zhang Ying	Supervisors
Liang Yun Bo	Core technical personnel
Zhang Jia Hong	senior management
Li Guo	Directors, senior managers
Ding Zhong Hui	Directors, senior managers, core technical personn
Gu Xiao Feng	Directors, senior managers
Wu Tong	Director
Wu Shi Ming	Director
Pei Yan Bin	senior management
Wang Xiao Qing	Supervisors
Zhang Chao Hui	Director

Beijing Succeeder Technology Headlines

No Headlines